stage iva verrucous carcinoma of the larynx
Showing 1 - 15 of 15
Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Squamous
Recruiting
- Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
- +50 more
- transoral robotic surgery
- quality of life assessment
-
Columbus, OhioOhio State University Medical Center
Oct 28, 2022
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- PI3K inhibitor BKM120
- cetuximab
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Sep 14, 2021
Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell
Active, not recruiting
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +29 more
- Cytology specimen
- Laboratory biomarker analysis
-
Philadelphia, PennsylvaniaThomas Jefferson University
Aug 31, 2021
Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell
Terminated
- Stage III Squamous Cell Carcinoma of the Hypopharynx
- +11 more
- cetuximab
- +3 more
-
Newark, New JerseyNew Jersey Medical School
Apr 19, 2021
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma, Stage 0
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +57 more
- placebo
- +3 more
-
Columbus, OhioOhio State University Medical Center
Feb 18, 2020
Mucositis, Oral Complications, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Trial in United States (acetylcysteine, ,
Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the
Completed
- Human Papilloma Virus Infection
- +15 more
- paclitaxel
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Aug 10, 2018
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +36 more
- sorafenib tosylate
- +3 more
-
Columbus, OhioArthur G. James Cancer Hospital and Solove Research Institute at
May 22, 2018
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Terminated
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +45 more
- talactoferrin
- laboratory biomarker analysis
-
Stanford, CaliforniaStanford University
Jul 30, 2016
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +35 more
- dasatinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 17, 2014
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Stage III Squamous Cell Carcinoma of the
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +26 more
- erlotinib hydrochloride
- +5 more
-
Cleveland, OhioCase Western Reserve University
Jun 5, 2014
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +38 more
- saracatinib
- laboratory biomarker analysis
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 2, 2014
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With
Completed
- Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
- +33 more
- ixabepilone
- laboratory biomarker analysis
-
Boston, MassachusettsEastern Cooperative Oncology Group
Feb 26, 2013
Anaplastic Thyroid Cancer, Insular Thyroid Cancer, Metastatic Parathyroid Cancer Trial in San Antonio (gefitinib)
Completed
- Anaplastic Thyroid Cancer
- +85 more
-
San Antonio, TexasSouthwest Oncology Group
Jan 11, 2013